About us
Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.
Our purpose
We connect science and compassion to reimagine mental health care.
Millions of people across the world live with mental illnesses for which there are few good options.
We are determined to change that.
Our first major initiative is developing investigational COMP360 psilocybin treatment through a global phase 3 programme for people living with treatment-resistant depression. Read more about our science.
Our stories
Everyone has a story about how mental illness has affected them or someone they know. Our people bring their stories, and a wide range of backgrounds and skills, to Compass.
Our values
We’ve put a lot of thought into the kind of organisation we want to be, and our values guide every decision we make. They define who we are, what we do, and how we do it.
Our approach
We are motivated by what is right for patients, and by the need to advance research, through considered collaboration with partners who share our vision.
-
We’re working to ensure our therapies are broadly and equitably accessible to all who might be helped by them
-
We work to the highest standards of scientific rigour and integrity
-
We’re committed to collaborating with others to advance science that could lead to improved patient outcomes
-
We publish all clinical study results, positive and negative, and encourage publication of all results from independent studies that use COMP360 psilocybin
-
We develop our clinical research programme using recommended scientific processes from regulatory agencies
60 seconds with …
…. Compass. Each month we speak to different members of our team about their work, life, and passions.
